The Board resolution dated December 10, 2021, the BOD of Imexpharm Corporation approved the following contents:

1)      Approving the record date to implement rights to collect shareholders’ opinions in writing:

-          Record date: January 01, 2022

-          Purpose: to collect shareholders’ opinions in writing.

-          Content:

+Amendment, supplement of the company’s charter; Regulation on Corporate Internal Governance; Regulation on organizing online the General Meeting of Shareholders.

+Proposal on approving the maximum foreign ownership ratio at IMP to 75%

+Proposal on the public offer tender for the transfer of shares between SK Investment Vina III Pte. Ltd and its existing shareholders.

-          Time of implementation: from January 12, 2022 to January 27, 2021.

2)      Approving the documents to collect shareholders’ opinions in writing:

-          Form to collect shareholders’ opinions in writing;

-          Proposal on amendment, supplement of the company’s charter; Regulation on Corporate Internal Governance; Regulation on organizing online the General Meeting of Shareholders.

-          Proposal on the maximum foreign ownership ratio at IMP to 75%.

-          Proposal on the public offer tender for SK Investment Vina III Pte. Ltd.

-          Draft of the Resolution of General Meeting of Shareholders.